← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2006Last known activity
Dec 20, 2017
Acquired by Merck on Feb 21, 2018
Timeline
2000s
- Jan 1, 2006
Viralytics— Founded
2010s
- Feb 21, 2018
Merck— Acquired By
Drugs by trial phase (6 distinct, 12 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT03408587Lead sponsorPhase 1Dec 20, 2017
- NCT02824965CollaboratorPhase 1Jul 1, 2016
- NCT02565992Lead sponsorPhase 1Oct 1, 2015
- NCT02307149Lead sponsorPhase 1Feb 1, 2015
- NCT02316171Lead sponsorPhase 1Dec 1, 2014
- NCT02043665Lead sponsorPhase 1Jan 1, 2014
- NCT01636882Lead sponsorPhase 2Jun 1, 2012
- NCT01227551Lead sponsorPhase 2Oct 1, 2011
- NCT00832559Lead sponsorPhase 1Jan 1, 2009
- NCT00832559Reponsible party - principal investigatorPhase 1Jan 1, 2009
- NCT00636558Lead sponsorPhase 1Mar 1, 2008
- NCT00438009Lead sponsorPhase 1Feb 1, 2007
- NCT00235482Lead sponsorPhase 1Aug 1, 2005
Details
- Founded
- Sydney, AU Jan 1, 2006
- Last known activity
- Dec 20, 2017